<DOC>
	<DOCNO>NCT00728403</DOCNO>
	<brief_summary>The study 2 phase double blind randomize placebo control trial . The objective ass metabolic therapeutic effect American Ginseng ( Panax quinquefolius L. ) extract Korean Red Ginseng ( steam Panax C.A . Meyer ) extract management type 2 diabetes 12 week period . One Hundred twenty subject type 2 diabetes ( hyperglycemia key inclusion criterion : HbAlc≥6.5 % - ≤ 8.1 % ) participate study ( 36 men 36 post-menopausal woman ) .</brief_summary>
	<brief_title>Metabolic Therapeutic Effects American Korean Red Ginseng Treatment Type 2 Diabetes</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<criteria>presence type 2 diabetes ( least 1 year ) define A1c ≥6.5 % ≤8.1 % , recruitment , treatment diet oral hypoglycemic medication unchanged start least 2 month prior begin study ( recruitment , week 8 ) age 40 75 year systolic blood pressure &lt; 140 diastolic blood pressure &lt; 90 clinically euthyroid ( measure T3 T4 ) normal renal liver function postmenopausal nonpregnant woman ( Postmenopausal include : female year cessation menstruation ) negative result pregnancy test administer screening subject take effective form birth control ( example : condom , abstinence , etc . ) willing comply study protocol sign consent form individual bleed disorder individual allergy nitroglycerin plan surgery , pregnancy breastfeed take insulin ; clinically significant diabetes complication ( retinopathy , nephropathy , neuropathy ) ; serum triglyceride ≥ 4.5 mmol/L increase A1c level 2 % baseline study history angina heart attack use ginseng natural health product glucose modulate and/or antiplatelet activity within 2 month BMI &gt; 35 kg/m2 include weight fluctuation + 2kg treatment period smoke cigarette ; alcohol intake &gt; 2 drinks/day presence condition , opinion investigator , might jeopardize health safety subject study personnel adversely affect study result , subject participate study Subjects take Warfarin Coumadin , prescription NSAIDs , chronic use highdose ( &gt; 81mg ) nonprescription NSAIDs , selective serotonin reuptake inhibitor monoamine oxidase inhibitor , sympathomimetics medication affect nitric oxide level , know suspected sensitivity ingredient test product placebo participate study .</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>July 2015</verification_date>
</DOC>